Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair-Reference-Cited by-同舟云学术

Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair

Published:2018-10-23 Issue:6 Volume:113 Page:
ISSN:0300-8428
Container-title:Basic Research in Cardiology
language:en
Short-container-title:Basic Res Cardiol

Author:

Mehra Parul,Guo Yiru,Nong Yibing,Lorkiewicz Pawel,Nasr Marjan,Li Qianhong,Muthusamy Senthilkumar,Bradley James A.,Bhatnagar Aruni,Wysoczynski Marcin,Bolli Roberto,Hill Bradford G.

Funder

Foundation for the National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://link.springer.com/article/10.1007/s00395-018-0703-0/fulltext.html

Reference81 articles.

1. Action to Control Cardiovascular Risk in Diabetes Study G, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT, Action to Control Cardiovascular Risk in Diabetes Study G (2008) Effects of intensive glucose lowering in type 2 diabetes. The N Engl J Med 358:2545–2559. https://doi.org/10.1056/nejmoa0802743

2. Aguiari P, Leo S, Zavan B, Vindigni V, Rimessi A, Bianchi K, Franzin C, Cortivo R, Rossato M, Vettor R, Abatangelo G, Pozzan T, Pinton P, Rizzuto R (2008) High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci USA 105:1226–1231. https://doi.org/10.1073/pnas.0711402105

3. Albiero M, Poncina N, Tjwa M, Ciciliot S, Menegazzo L, Ceolotto G, Vigili de Kreutzenberg S, Moura R, Giorgio M, Pelicci P, Avogaro A, Fadini GP (2014) Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1. Diabetes 63:1353–1365. https://doi.org/10.2337/db13-0894

4. Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, El Nakadi B, Banovic M, Beleslin B, Vrolix M, Legrand V, Vrints C, Vanoverschelde JL, Crespo-Diaz R, Homsy C, Tendera M, Waldman S, Wijns W, Terzic A (2013) Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol 61:2329–2338. https://doi.org/10.1016/j.jacc.2013.02.071

5. Bolli R, Chugh AR, D’Amario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P (2011) Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 378:1847–1857. https://doi.org/10.1016/S0140-6736(11)61590-0

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell-based therapy in cardiac repair after myocardial infarction: Promise, challenges, and future directions;Journal of Molecular and Cellular Cardiology;2024-03

2. PU.1 inhibition does not attenuate cardiac function deterioration or fibrosis in a murine model of myocardial infarction;Molecular and Cellular Biochemistry;2022-09-17

3. miR-133a—A Potential Target for Improving Cardiac Mitochondrial Health and Regeneration After Injury;Journal of Cardiovascular Pharmacology;2022-08

4. Progressive stages of dysmetabolism are associated with impaired biological features of human cardiac stromal cells mediated by the oxidative state and autophagy;The Journal of Pathology;2022-07-28

5. Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure;Circulation;2022-04-26